The final, formatted version of the article will be published soon. Introduction: Sacrocolpopexy with concomitant hysterectomy is a common procedure for the treatment of pelvic organ prolapse. However ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, comparing it to standard chemotherapy. The trial targets patients with ...

Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Recent clinical advances ...

Dr Bradley J. Monk explores the RUBY trial's findings, highlighting the survival benefits of adding dostarlimab to chemotherapy for endometrial cancer treatment. Bradley J. Monk, MD, Florida Cancer ...

Endometrial polyps are small growths within the uterine lining that can cause spotting between periods. They are sometimes associated with infertility and in rare cases, cancer. Endometrial polyps ...

Taking at least 30 ibuprofen pills per month was associated with a significant reduction in the risk of endometrial cancer when compared to taking fewer than 4 pills per month. Frequent use of ...

aDepartment of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria bDepartment of Radiation Oncology, Medical University of Vienna, Vienna, Austria cDepartment of ...

You can usually return to sexual intimacy two weeks after endometrial ablation, but get the okay from your provider first. Discuss other forms of intimacy that you and your partner can enjoy while you ...

Increased endometrial thickness is a potential sign of endometrial cancer. Doctors are most likely to be concerned if you also experience bleeding. Endometrial thickness refers to the thickness of the ...

Schonfeld SJ, Hartge P, Pfeiffer, RM, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer 2012 Dec 20. doi: 10.1002/cncr.27909. [Epub ahead of print] It is ...